(Q61956320)
Statements
Dose-response Relationship of Five Dose Levels of NNC90-1170 and Placebo on Glycaemic Control in Type 2 Diabetic Patients Compared to OHA Treatment. A 12-week Multi-centre, Double-blind, Randomised, Parallel Group Trial With an Open Labelled OHA Arm (English)
0 references
October 2000
0 references
October 2001
0 references
196
0 references
30 year
0 references
75 year
0 references